Siebels, M <br/><br/>
[Metastatic renal cell cancer in Germany in 2010. Impact of different target therapies].  [electronic resource] 

 -  Der Urologe. Ausg. A  Sep 2011 
 - 1110-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1433-0563 
<br/><br/><label>Standard No.: </label>10.1007/s00120-011-2553-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Benzenesulfonates--administration & dosage<br/>Carcinoma, Renal Cell--drug therapy<br/>Data Collection<br/>Disease Progression<br/>Drug Delivery Systems<br/>Everolimus<br/>Female<br/>Germany<br/>Humans<br/>Indoles--administration & dosage<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Practice Patterns, Physicians'<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyridines--administration & dosage<br/>Pyrroles--administration & dosage<br/>Sirolimus--administration & dosage<br/>Sorafenib<br/>Sunitinib<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors